Signal from the log
Cognito Therapeutics
105 M$ · Undisclosed · United States · Medtech
Société de Cambridge, dans le Massachusetts, qui développe Spectris, un appareil à domicile traitant la maladie d'Alzheimer par stimulation sensorielle, lumière et son, sans médicament ni chirurgie. Le tour finance l'essai pivot HOPE, 673 participants sur 70 sites, en vue d'une mise sur le marché en 2027.
Verified
Announced on , logged by the watch of 12 August 2026.
- Operation
- Funding round
- Announced amount
- 105 M$
- Stage
- Undisclosed
- Country
- United States
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Morningside Ventures , IAG Capital Partners , Starbloom Capital , with New Vintage , Apollo Health Ventures , Benvolio Group
Provenance
Source longevity
Logged on 12 August 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.